SCIENTIST HOME FUTURE HEALTH LTD
OOTC:SHFH1.70
USD
0.00
(0.00%)
CIK
2032609
ISIN
US8089251016
CUSIP
808925101
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
USD
•
in mil. unless spec.Working Capital
USD
•
in mil. unless spec.Growth Rates
USD
•
in mil. unless spec.Quarterly Revenue
USD
•
in mil. unless spec.Quarterly Earnings Per Share
USD
•
in mil. unless spec.Quarterly Dividends Per Share
USD
•
in mil. unless spec.Company Description
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Hong Kong Hong Kong
- CIK
- 0002032609
- Similar Companies
- Business
- Scientist Home Future Health Ltd. is a healthcare and wellness company engaged in the retail distribution of nutritional dietary supplements, specialized topical creams, and the provision of preventive health screening and rehabilitation services. Operating through two core business segments, Retail Trading and Healthcare Services, the company develops and commercializes wellness solutions focused on degenerative diseases, chronic conditions, and preventive personal care. Its product portfolio comprises dietary and wellness supplements, including hydrolyzed collagen formulations, gelatin hydrolysate powders, joint and bone health supplements, cardiovascular support capsules, blood pressure regulators, uric acid management formulas, prostate support products, and neurological health supplements; therapeutic topical creams and ointments, including spermaceti-based creams, cetylated fatty acid formulations designed for joint mobility and muscular relief, and anti-inflammatory skincare preparations. Within its service operations, the company provides comprehensive physical check-up examinations; routine diagnostic health screenings; personalized wellness consultations; and interdisciplinary rehabilitation programs tailored for geriatric populations, athletes, and health-conscious consumers. Incorporated in Nevada in July 2024, Scientist Home Future Health Ltd. maintains its principal executive headquarters in Kwun Tong, Hong Kong, and conducts its primary commercial operations throughout Hong Kong and broader Asian markets primarily through its wholly owned subsidiary, Scientist Home Future Health Limited (Hong Kong). In recent developments, the company established its public market presence on the U.S. Over-the-Counter market under the ticker symbol SHFH following its corporate organization. Furthermore, the company expanded its clinical development and therapeutic scope by entering into a strategic investment agreement for an evidence-based nutritional therapy targeting severe eczema, securing an initial equity stake with milestone-contingent expansion rights following positive clinical trial outcomes, while actively scaling its retail distribution channels and marketing infrastructure across regional Asian markets.